Hanbo Le

956 total citations
29 papers, 760 citations indexed

About

Hanbo Le is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Hanbo Le has authored 29 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Hanbo Le's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer-related molecular mechanisms research (7 papers). Hanbo Le is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (10 papers) and Cancer-related molecular mechanisms research (7 papers). Hanbo Le collaborates with scholars based in China and Austria. Hanbo Le's co-authors include Yongkui Zhang, Wangyu Zhu, Jian-Ying He, Dongdong Chen, Yanyan Huang, Liyun Xu, Haijie Ma, Xiaoguang Liu, Xiaoguang Liu and Zhaoye Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Immunopharmacology.

In The Last Decade

Hanbo Le

27 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanbo Le China 13 473 437 175 143 121 29 760
Qihai Sui China 15 359 0.8× 244 0.6× 202 1.2× 259 1.8× 101 0.8× 41 591
Huili Chu China 12 442 0.9× 244 0.6× 276 1.6× 187 1.3× 65 0.5× 15 710
Yongfeng Wu China 10 370 0.8× 293 0.7× 181 1.0× 92 0.6× 67 0.6× 13 558
Inés López Spain 10 396 0.8× 258 0.6× 280 1.6× 198 1.4× 44 0.4× 18 664
Rubo Cao China 9 298 0.6× 248 0.6× 135 0.8× 53 0.4× 86 0.7× 25 480
Guowen Lin China 13 207 0.4× 162 0.4× 132 0.8× 224 1.6× 72 0.6× 20 466
Xu-Bao Shi United States 13 814 1.7× 737 1.7× 101 0.6× 174 1.2× 61 0.5× 15 1.0k
Meisongzhu Yang China 12 386 0.8× 220 0.5× 104 0.6× 114 0.8× 63 0.5× 16 524
Yuansheng Zheng China 11 323 0.7× 217 0.5× 166 0.9× 217 1.5× 67 0.6× 29 504
Xiangli Jiang China 14 307 0.6× 222 0.5× 171 1.0× 171 1.2× 45 0.4× 23 512

Countries citing papers authored by Hanbo Le

Since Specialization
Citations

This map shows the geographic impact of Hanbo Le's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanbo Le with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanbo Le more than expected).

Fields of papers citing papers by Hanbo Le

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanbo Le. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanbo Le. The network helps show where Hanbo Le may publish in the future.

Co-authorship network of co-authors of Hanbo Le

This figure shows the co-authorship network connecting the top 25 collaborators of Hanbo Le. A scholar is included among the top collaborators of Hanbo Le based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanbo Le. Hanbo Le is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhu, Wangyu, Huafeng Zhang, L.J. Tang, et al.. (2024). Identification of a Plasma Exosomal lncRNA‐ and circRNA‐Based ceRNA Regulatory Network in Patients With Lung Adenocarcinoma. The Clinical Respiratory Journal. 18(10). e70026–e70026. 2 indexed citations
3.
Zhang, Binjie, Zhijun Chen, Hanbo Le, et al.. (2024). Pathological and imaging features of pulmonary invasive mucinous adenocarcinoma—a retrospective cohort study. Translational Lung Cancer Research. 13(6). 1376–1382.
4.
Zhao, Qi, Ji Zhang, Hanbo Le, et al.. (2024). Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer. International Journal of Oncology. 65(2). 5 indexed citations
5.
Zhang, Chi, et al.. (2023). Increased TIM-3 expression in tumor-associated macrophages predicts a poorer prognosis in non-small cell lung cancer: a retrospective cohort study. Journal of Thoracic Disease. 15(3). 1433–1444. 11 indexed citations
6.
Chen, Cheng, Zhijun Chen, Wu-Jun Li, et al.. (2022). Impact of minimal solid and micropapillary components on invasive lung adenocarcinoma recurrence. Annals of Diagnostic Pathology. 59. 151945–151945. 9 indexed citations
8.
Zhu, Wangyu, Xiaofei Hu, Ri Cui, et al.. (2019). Prognostic value of mutant p53, Ki-67, and TTF-1 and their correlation with EGFR mutation in patients with non-small cell lung cancer.. PubMed. 34(11). 1269–1278. 11 indexed citations
9.
10.
Zhu, Wangyu, Haifeng Li, Bing‐Jie Zhang, et al.. (2018). Epidermal Growth Factor Receptor Mutations and Their Prognostic Value with Carcinoembryonic Antigen in Pathological T1 Lung Adenocarcinoma. Disease Markers. 2018. 1–13. 4 indexed citations
12.
Zhang, Yongkui, et al.. (2017). Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer. World Journal of Surgical Oncology. 15(1). 64–64. 23 indexed citations
14.
Ye, Bo, Liyun Xu, Zhaoyu Wang, et al.. (2016). [Establishment of A Clinical Prediction Model of Solid Solitary Pulmonary Nodules].. SHILAP Revista de lepidopterología. 19(10). 705–710. 10 indexed citations
15.
Wang, Lie, Zhijun Chen, Yongkui Zhang, & Hanbo Le. (2015). The role of mitochondrial tRNA mutations in lung cancer.. PubMed. 8(8). 13341–6. 15 indexed citations
16.
Zhu, Wangyu, Jian-Ying He, Dongdong Chen, et al.. (2014). Expression of miR-29c, miR-93, and miR-429 as Potential Biomarkers for Detection of Early Stage Non-Small Lung Cancer. PLoS ONE. 9(2). e87780–e87780. 128 indexed citations
17.
Xu, Liyun, Dongdong Chen, Jian-Ying He, et al.. (2014). Tim-3 Expression by Peripheral Natural Killer Cells and Natural Killer T Cells Increases in Patients with Lung Cancer - Reduction after Surgical Resection. Asian Pacific Journal of Cancer Prevention. 15(22). 9945–9948. 19 indexed citations
18.
Le, Hanbo, Zeng Fang, Liyun Xu, Xiaoguang Liu, & Yanyan Huang. (2013). The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Molecular Medicine Reports. 8(5). 1511–1518. 18 indexed citations
19.
Zhang, Yongkui, Wangyu Zhu, Jian-Ying He, et al.. (2012). miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. Journal of Cancer Research and Clinical Oncology. 138(10). 1641–1650. 57 indexed citations
20.
Le, Hanbo, Wangyu Zhu, Dongdong Chen, et al.. (2012). Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Medical Oncology. 29(5). 3190–3197. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026